These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31366871)

  • 1. Changes in Bile Acid Concentrations after Administration of Ketoconazole or Rifampicin to Chimeric Mice with Humanized Liver.
    Sanoh S; Tamura Y; Fujino C; Sugahara G; Yoshizane Y; Yanagi A; Kisoh K; Ishida Y; Tateno C; Ohta S; Kotake Y
    Biol Pharm Bull; 2019; 42(8):1366-1375. PubMed ID: 31366871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
    Ali I; Khalid S; Stieger B; Brouwer KLR
    Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
    Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
    Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats.
    Yang F; Takeuchi T; Tsuneyama K; Yokoi T; Oda S
    Toxicol Sci; 2019 Jul; 170(1):95-108. PubMed ID: 30985903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanshinone IIA alleviate rifampicin-induced cholestasis by regulating the expression and function of bile salt export pump.
    Liu L; Yang Y; Li W; Li Y; Jiang X; Wang L
    Hum Exp Toxicol; 2022; 41():9603271221097365. PubMed ID: 35544702
    [No Abstract]   [Full Text] [Related]  

  • 7. Danning tablets attenuates α-naphthylisothiocyanate-induced cholestasis by modulating the expression of transporters and metabolic enzymes.
    Ding L; Zhang B; Zhan C; Yang L; Wang Z
    BMC Complement Altern Med; 2014 Jul; 14():249. PubMed ID: 25033983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related liver injury of Geniposide associated with the alteration in bile acid synthesis and transportation.
    Tian J; Zhu J; Yi Y; Li C; Zhang Y; Zhao Y; Pan C; Xiang S; Li X; Li G; Newman JW; Feng X; Liu J; Han J; Wang L; Gao Y; La Frano MR; Liang A
    Sci Rep; 2017 Aug; 7(1):8938. PubMed ID: 28827769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury.
    Zhou Y; Li M; Cao Y; Chang W; Jia H; Wang L; Xu H; Wang Y; Liu P; Chen WD
    Int Immunopharmacol; 2024 Sep; 139():112799. PubMed ID: 39068755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From hazard to risk prioritization: a case study to predict drug-induced cholestasis using physiologically based kinetic modeling.
    de Bruijn VMP; Rietjens IMCM
    Arch Toxicol; 2024 Sep; 98(9):3077-3095. PubMed ID: 38755481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
    Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
    Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising toxicological biomarkers for the diagnosis of liver injury types: Bile acid metabolic profiles and oxidative stress marker as screening tools in drug development.
    Masubuchi N; Nishiya T; Imaoka M; Mizumaki K; Okazaki O
    Chem Biol Interact; 2016 Aug; 255():74-82. PubMed ID: 26365562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimesulide and 4'-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis.
    Zhou L; Pang X; Jiang J; Zhong D; Chen X
    Drug Metab Dispos; 2017 May; 45(5):441-448. PubMed ID: 28202577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis.
    Karsten REH; Krijnen NJW; Maho W; Permentier H; Verpoorte E; Olinga P
    Arch Toxicol; 2022 Sep; 96(9):2523-2543. PubMed ID: 35708773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pinelliae Rhizoma Praeparatum Involved in the Regulation of Bile Acids Metabolism in Hepatic Injury.
    Guo S; Zhang S; Liu L; Yang P; Dang X; Wei H; Hu N; Shi L; Zhang Y
    Biol Pharm Bull; 2018 Jun; 41(6):869-876. PubMed ID: 29618704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleanolic acid alters bile acid metabolism and produces cholestatic liver injury in mice.
    Liu J; Lu YF; Zhang Y; Wu KC; Fan F; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):816-24. PubMed ID: 23948738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids.
    González R; Cruz A; Ferrín G; López-Cillero P; Briceño J; Gómez MA; Rufián S; Padillo J; De la Mata M; Marin JJ; Muntané J
    J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):740-50. PubMed ID: 21526375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
    Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
    J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.
    Garzel B; Zhang L; Huang SM; Wang H
    Curr Drug Metab; 2019; 20(8):621-632. PubMed ID: 31288715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
    Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
    J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.